Tag: SELECT-COMPARE

Switching upadacitinib and adalimumab is beneficial in refractory RA

Trial
Phase 3, SELECT-COMPARE
Conference
EULAR 2019
Type
Peer-reviewed article

4 September 2019 17:54
site created by:   

© 2024 Medicom Medical Publishers.  All rights reserved. Terms and Conditions | Privacy Policy



HEAD OFFICE
Laarderhoogtweg 25
1101 EB Amsterdam
The Netherlands
T: +31 85 4012 560
E: publishers@medicom-publishers.com